Literature DB >> 3166548

Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland.

P Hamilton, D Middleton.   

Abstract

The normal distribution in Northern Ireland of the genetic markers properdin factor B (Bf) and glyoxalase I (GLO) are described. These markers are available for comparison in disease studies, family studies and paternity studies.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3166548      PMCID： PMC2448479     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


  8 in total

1.  Age relationship between insulin-dependent diabetes and rare alleles of properdin factor B.

Authors:  R L Kirk; S W Serjeantson; J Theophilus; P Zimmet; S Whitehouse; J M Court
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

2.  DR antigens and Bf allotypes in north-east England.

Authors:  S S Papiha; M F Duggan-Keen; R S Rodger
Journal:  Hum Hered       Date:  1985       Impact factor: 0.444

Review 3.  HLA and disease 1982--a survey.

Authors:  A Svejgaard; P Platz; L P Ryder
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  HLA-DR antigens and properdin factor B allotypes in responders and non-responders to the Rhesus-D antigen.

Authors:  C Darke; J Street; C Sargeant; P A Dyer
Journal:  Tissue Antigens       Date:  1983-04

5.  Properdin factor B alleles in patients with idiopathic membranous nephropathy.

Authors:  P A Dyer; P T Klouda; R Harris; N P Mallick
Journal:  Tissue Antigens       Date:  1980-05

6.  Polymorphism of red cell glyoxalase I (EI: 4.4.1.5); a new genetic marker in man. Investigation of 169 mother-child combinations.

Authors:  J Kömpf; S Bissbort; S Gussmann; H Ritter
Journal:  Humangenetik       Date:  1975

7.  HLA-A, B, Bf three point association of 1,072 haplotypes in a German population.

Authors:  J Bertrams; M P Baur
Journal:  Tissue Antigens       Date:  1979-10

8.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.